THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$260.85
0.92 (0.35%)
▲
5d:
+2.97%
30d:
+33.9%
90d:
+36.09%
WAIT
LOW Confidence
Analysis Updated: Aug 10, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: THC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: THC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$243.99
Based on 0.6% avg growth
INTRINSIC VALUE TODAY
$151.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $260.85, which is considered extended relative to its 30-day fair value range of $196.75 to $254.46. The stock's valuation (Forward PE: 12.6) is in line with its historical norms (11.5). At these levels, the market is pricing in 3.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, THC is in a uptrend. The price is approaching resistance at $265.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: THC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, THC is in a uptrend. The price is approaching resistance at $265.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: THC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$196.75 -
$254.46
Company Quality Score
29/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
39.2%
Protect Your Profits
Holding THC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($279.86)
- NEUTRAL: Market pricing in 3.0% annual earnings growth - fairly valued
- WARNING: Composite score 29/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$196.75 -
$254.46
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$14.92
(5.7%)
Support & Resistance Levels
Support Level
$244.44
Resistance Level
$265.32
Current Trend
Uptrend
Technical data as of
Aug 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.61
Wall Street Target
$279.86
(+7.7%)
Revenue Growth (YoY)
6.8%
Earnings Growth (YoY)
213.4%
Profit Margin
10.3%
Valuation Premium vs History
+3.0% premium
PE vs Historical
12.6 vs 11.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$267.73
(+3%)
2-Year Target
$275.76
(+6%)
3-Year Target
$284.03
(+9%)
3-Yr Target (if PE normalizes)
(PE: 13→12)
PE COMPRESSION
$259.13
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: -2.8%)
$382.84
(+47%)
Base:
(SPY PE: 12.6, Growth: -2.8%)
$238.54
(-8%)
Bear:
(PE: 10.7, Growth: -2.8%)
$202.76
(-22%)
📈
Valuation based on Current Earnings
Trailing PE: 10.13 | Current EPS (TTM): $25.87
Bull Case
$229.84
(-12%)
Analyst growth -20.3%, PE expands to 11.2
Base Case
$208.94
(-20%)
Market implied -20.3%, PE stable at 10.1
Bear Case
$178.25
(-31%)
Severe decline -20.0%, PE contracts to 8.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 11, 2026 1:30 PM ET
Data refreshes hourly during market hours. Next update: 2:30 PM
Data refreshes hourly during market hours. Next update: 2:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Paola M Arbour
SELL
6500 shares
2026-03-11
Thomas W Arnst
SELL
8000 shares
2026-03-09
R. Scott Ramsey
SELL
8017 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 31 SELL |
|
ASTH
Astrana Health Inc |
STRONG BUY
12 analysts |
$51 | 69 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$144 | 36 SELL |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 45 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$34 | 49 HOLD |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
